InflaRx N.V. (IFRX)
NASDAQ: IFRX · IEX Real-Time Price · USD
1.551
+0.031 (2.04%)
Jul 22, 2024, 9:51 AM EDT - Market open
InflaRx Employees
InflaRx had 62 employees as of December 31, 2023. The number of employees increased by 18 or 40.41% compared to the previous year.
Employees
62
Change (1Y)
18
Growth (1Y)
40.41%
Revenue / Employee
$1,732
Profits / Employee
-$720,693
Market Cap
90.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
LakeShore Biopharma | 773 |
Alpha Teknova | 211 |
Asensus Surgical | 209 |
HilleVax | 90 |
BeyondSpring | 36 |
Eton Pharmaceuticals | 30 |
Eupraxia Pharmaceuticals | 29 |
Cellectar Biosciences | 20 |
IFRX News
- 4 weeks ago - InflaRx's GOHIBIC (Vilobelimab) Selected for First BARDA-Sponsored Clinical Trial to Evaluate Novel Host-Directed Therapeutics for Acute Respiratory Distress Syndrome (ARDS) - GlobeNewsWire
- 6 weeks ago - InflaRx Hosts R&D Event Highlighting the Promise of INF904 - GlobeNewsWire
- 2 months ago - InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators - GlobeNewsWire
- 2 months ago - InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event - GlobeNewsWire
- 4 months ago - InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans - GlobeNewsWire
- 4 months ago - InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024 - GlobeNewsWire
- 5 months ago - InflaRx Appoints Jan Medina as Head of Investor Relations - GlobeNewsWire